Integrative Cancer Epidemiology Programme 2
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
TAYLOR J. et al, (2022), Genetics in Medicine
The health economics component of this major programme of research on cancer epidemiology will develop new causal evidence on the effect of cancers on healthcare cost and on health-related quality of life. The work will also explore the potential for genetic data to influence the cost-effectiveness of screening programmes.
Oxford project lead:
Richard Martin, University of Bristol
2020 – 2025
Cancer Research UK